Back
Cidara Therapeutics Vs. Cue Biopharma Industry Stock Comparison
Buy
62
CDTX
Cidara Therapeutics
Last Price:
13.18
Seasonality Move:
7.06%
Buy
54
CUE
Cue Biopharma
Last Price:
1.52
Seasonality Move:
22.34%
Buy
62
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
- The current Cidara Therapeutics [CDTX] share price is $13.03. The Score for CDTX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- CDTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Cue Biopharma (CUE)
is a Buy
Is Cue Biopharma a Buy, Sell or Hold?
- The current Cue Biopharma [CUE] share price is $1.49. The Score for CUE is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- CUE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $13.03
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing selling pressure, which indicates risk of future bearish movement.
CUE Stock Price Chart
What is Cue Biopharma's stock price today?
-
The Cue Biopharma share price today is $1.49
The current trend is moderately bullish and CUE is experiencing selling pressure, which indicates risk of future bearish movement.
CDTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.51 | Buy |
Relative Strength Index (14 RSI): | 65.74 | Buy |
Chaikin Money Flow: | -17467 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.44 - 12.42) | Buy |
Bollinger Bands (100): | (11.01 - 12.73) | Buy |
CUE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.19 | Buy |
Relative Strength Index (14 RSI): | 56.61 | Buy |
Chaikin Money Flow: | -268792 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1 - 1.64) | Buy |
Bollinger Bands (100): | (0.59 - 1.31) | Buy |
CDTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.7 | Buy |
20-day SMA: | 11.59 | Buy |
50-day SMA: | 11.53 | Buy |
200-day SMA: | 12.96 | Buy |
8-day EMA: | 12.66 | Buy |
20-day EMA: | 11.99 | Buy |
50-day EMA: | 11.74 | Buy |
200-day EMA: | 13.15 | Sell |
CUE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.61 | Sell |
20-day SMA: | 1.44 | Buy |
50-day SMA: | 0.96 | Buy |
200-day SMA: | 1.46 | Buy |
8-day EMA: | 1.56 | Sell |
20-day EMA: | 1.4 | Buy |
50-day EMA: | 1.14 | Buy |
200-day EMA: | 1.46 | Buy |
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $17.37 per share, and an increase next year of $26.43 per share.
Cue Biopharma Earnings Growth & CUE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.46 per share, and an increase next year of $0.07 per share.
Cidara Therapeutics Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cue Biopharma Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |